Maiko A Schneider
Overview
Explore the profile of Maiko A Schneider including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schneider M, Malhotra D, Spritzer P, Hatchard T, Minuzzi L, Frey B, et al.
Neuroendocrinology
. 2022 Sep;
113(5):489-500.
PMID: 36130584
Introduction: The cognitive effects of cross-sex hormone therapy (CSHT) are not well understood. In cisgender individuals, sex hormone therapy can impact neurotransmitter levels and structural anatomy. Similarly, in gender-diverse persons,...
2.
Varghese S, Frey B, Schneider M, Kapczinski F, de Azevedo Cardoso T
Acta Psychiatr Scand
. 2021 Nov;
145(2):156-185.
PMID: 34758106
Objectives: To describe the cognitive and functional impairment in individuals with the first episode of major depressive disorder (MDD) as compared to controls and individuals with recurrent MDD. Also to...
3.
Mioduszewski O, Hatchard T, Fang Z, Poulin P, Khoo E, Romanow H, et al.
J Cancer Surviv
. 2020 Jun;
14(6):915-922.
PMID: 32557211
Purpose: The present study explores the benefits of an 8-week mindfulness-based stress reduction (MBSR) program to white matter integrity among breast cancer survivors experiencing chronic neuropathic pain (CNP). Methods: Twenty-three...
4.
Schneider M, Spritzer P, Suh J, Minuzzi L, Frey B, Schwarz K, et al.
Neuroendocrinology
. 2019 Aug;
110(6):489-500.
PMID: 31461715
For transgender individuals, gender-affirming surgery (GAS) and cross-sex hormone therapy (CSHT) are part of the gender transition process. Scientific evidence supporting the maintenance of CSHT after GAS-related gonadectomy is accumulating....
5.
Schneider M, Spritzer P, Minuzzi L, Frey B, Syan S, Fighera T, et al.
Front Neurosci
. 2019 Aug;
13:817.
PMID: 31440128
An extreme incongruence between sex and gender identity leads individuals with gender dysphoria (GD) to seek cross-sex hormone therapy (CSHT), and gender-affirming surgery (GAS). Although few studies have investigated the...
6.
Schneider M, Spritzer P, Soll B, Fontanari A, Carneiro M, Tovar-Moll F, et al.
Front Hum Neurosci
. 2017 Nov;
11:528.
PMID: 29184488
Gender dysphoria (GD) (DMS-5) is a condition marked by increasing psychological suffering that accompanies the incongruence between one's experienced or expressed gender and one's assigned gender. Manifestation of GD can...
7.
Schneider M, Andreazza T, Fontanari A, Costa A, da Silva D, Aguiar B, et al.
Trends Psychiatry Psychother
. 2017 Apr;
39(1):43-47.
PMID: 28403322
Introduction:: Transsexualism (ICD-10) is a condition characterized by a strong and persistent dissociation with one's assigned gender. Sex reassignment surgery (SRS) and hormone therapy provide a means of allowing transsexual...